Allan D. Hess - Concepedia

Author

Allan D. Hess

Johns Hopkins University

Also Known As

A D Hess, A D. Hess, A Hess, A. D. Hess, A. HESS, A. Hess, A.D. HESS, A.D. Hess, ALLAN D. HESS, Allan D Hess

218

Publications

6.4K

Citations

H-Index

122

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Cancer Center Mayo Clinic

About

Allan D. Hess is an author at Johns Hopkins University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	49	2.2K
2	Natural Sciences	2	2	143
3	Education	1	1	13
4	Health Sciences	1	1	24
5	Social Sciences	1	1	56

Allan D. Hess

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Blood	2010	396
Thalidomide for the Treatment of Chronic Graft-versus-Host Disease Georgia B. Vogelsang, Evan R. Farmer, Allan D. Hess, New England Journal of Medicine	1992	393
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak, Science Translational Medicine	2013	354
Association of Foxp3 regulatory gene expression with graft-versus-host disease Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Blood	2004	312
Cyclosporin A Binding to Calmodulin: A Possible Site of Action on T Lymphocytes Paul M. Colombani, Adelaide Robb, Allan D. Hess Science ImmunologyImmune RegulationCyclosporin AAntigen ProcessingImmunotherapy	1985	281
Effect of cyclosporin A on human lymphocyte responses <i>in vitro</i>. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. Allan D. Hess, P. J. Tutschka The Journal of Immunology	1980	236
Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. Allan D. Hess, L Horwitz, W. E. Beschorner, The Journal of Experimental Medicine HistocompatibilityCell TherapyCsa TherapyImmunologyImmune Regulation	1985	204
Effect of cyclosporin A on human lymphocyte responses <i>in vitro</i>. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. Allan D. Hess, P. J. Tutschka, George W. Santos The Journal of Immunology	1982	154
Human immunodeficiency virus induces phosphorylation of its cell surface receptor Alan P. Fields, Daniel P. Bednarik, Allan D. Hess, Nature Cell Surface ReceptorHuman RetrovirusImmunologyAntiviral ResponseVirology	1988	130
Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design. L W Scheibel, Paul M. Colombani, Allan D. Hess, Proceedings of the National Academy of Sciences Parasitic DiseaseAntiparasitic AgentMalariaImmunologyCalcium Requirement	1987	104

Page 1